Skip to content
Medical Health Aged Care, Seniors Interest

Review highlights menopause research gaps and calls for a new definition

Monash University 2 mins read

A team of international experts has called for a new definition of menopause, more research and improved treatments following a comprehensive review published in the journal Cell.

Led by
Monash University Women’s Health Research Program head Professor Susan Davis, the review summarised menopause knowledge, called for more research into its timeline and treatment, and encouraged individualised, holistic treatment that addressed symptoms and systemic body changes.

“The road to menopause is not difficult for all, but for some, symptoms may be severe or even disabling and disruptive to work and family,” the Australian, Italian and US-based authors wrote.

“Recognition that menopause, for most women, is a natural biological event, does not exempt the use of interventions to alleviate symptoms. Optimising health at menopause is the gateway to healthy ageing for women.”


The researchers looked at more than 200 sources across 71 years to synthesise current knowledge. Key takeaways included:

  • A proposed new definition for menopause as “final cessation of ovarian function,” rather than the traditional focus on menstruation. Among other things this would encompass those without regular periods before menopause, who used certain types of contraception like IUDs, and had hysterectomies.
  • The timeline of menopause phases isn’t well understood and varies from person to person, so age restrictions on prescriptions and therapies are problematic and not always logical.
  • Menopause treatments range from hormone therapies to lasers to plant products, but few have been studied over long enough timespans.
  • Each treatment type has potential side effects and health concerns. Even the most effective and well-researched—hormone therapy targeting oestrogen—is far from a perfect solution for all.
  • Symptoms vary widely, from severe to none. Even if someone has no noticeable symptoms, there can still be significant “silent health consequences,” including bone loss and a higher risk of diabetes, cardiovascular diseases, and certain cancers.
  • Some symptoms, like short-term memory loss, can be temporary, and others, like depression and anxiety, can be pre-existing conditions falsely attributed to menopause due to stigma surrounding it.
  • Regular exercise and maintaining a protein-rich nutritious diet can reduce the likelihood of symptomatic health complications.
  • Socio-economic factors such as lower quality of life and the potential negative impact of menopausal symptoms on a woman’s work performance aren't often acknowledged.

Despite decades of menopause research, Prof
essor Davis and her colleagues said researchers needed to look deeper into when the process started and focus on making treatments more effective and safer overall.


They also underlined the importance of research outside high-income countries, and studying the impacts of menopause on work from home and in an office, as well as the impacts on people with less traditional career paths such as caregivers and volunteers.

Professor Davis and her co-authors said menopause treatments needed to be holistic and individually tailored, addressing physical and mental health impacts, as well as underlying associated health risks and any other relevant health concerns.

Optimal menopause-related care involves shared decision making which means quality, evidence-based information needs to be available for the general community and health care providers,” Professor Davis said.

Cell, Davis et al. “Menopause – Biology, Consequences, Supportive Care and Therapeutic Options.”

To download a copy of this paper, please visit:

For media enquiries please contact:


Author Contact:
Susan R Davis
Monash University

Monash University

Cheryl Critchley - Communications Manager (medical)

T: +61 (0) 418 312 596


For more Monash media stories, visit our news and events site 

For general media enquiries please contact:
Monash Media
T: +61 (0) 3 9903 4840




More from this category

  • Medical Health Aged Care
  • 29/11/2023
  • 23:22
Clairvoyant Therapeutics

Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (, the clinical-stage pharmaceutical company developing psilocybin therapy for alcohol use disorder (AUD), today announced that it has randomized more than 50 per cent of the expected 128 subjects for its 24-week Phase 2b clinical trial of synthetic psilocybin (25mg oral capsule). The double-blind, randomized controlled trial was initiated in October 2022 and is designed to assess multiple efficacy and safety endpoints."We are pleased that the pace of subject enrollment is at the upper end of our expectations. We are on track for an interim data read out…

  • Medical Health Aged Care
  • 29/11/2023
  • 12:07
Hola Health

Leading health tech firm named among fastest-growing Australian start-ups

Hola Health, a leading local health tech start-up providing telehealth and online script fulfillment services to a growing number of Australians, has been named in the top 5 fastest-growing new companies in the country in a prestigious annual list. The Australian Financial Review’s Fast Starters list recognises Australia’s 100 fastest-growing start-ups and young companies.It shows Hola Health grew revenue from around $100,000 in 2020/21 to $3.8 million last financial year. It is on track to exceed $10 million in revenue by the end of this financial year. In naming Hola Health at number five on the list, the AFR hailed…

  • Contains:
  • Medical Health Aged Care
  • 29/11/2023
  • 07:34
Public Health Association of Australia / Australian and New Zealand Journal of Public Health

New research reveals how babies and toddlers are targeted with unhealthy foods

Wednesday 29 November 2023 Babies and toddlers can't read or buy food yet, but new research reveals that they are being targeted with aggressive marketing in the baby and toddler aisle at the supermarket. The research, published today in theAustralian and New Zealand Journal of Public Health,has prompted health experts to call for regulation of on-pack labelling and promotional techniques used on baby and toddler food. Authors analysed 230 product packs found in two major supermarkets to uncover the marketing techniques used by manufacturers of products for children aged from just six months to three years. They found that 9…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.